dc.contributor.author |
Harms, Julia K |
en |
dc.contributor.author |
Lee, Tet-Woo |
en |
dc.contributor.author |
Wang, Tao |
en |
dc.contributor.author |
Lai, Amy |
en |
dc.contributor.author |
Kee, Dennis |
en |
dc.contributor.author |
Chaplin, John M |
en |
dc.contributor.author |
McIvor, Nick P |
en |
dc.contributor.author |
Hunter, Francis W |
en |
dc.contributor.author |
Macann, Andrew MJ |
en |
dc.contributor.author |
Wilson, William R |
en |
dc.contributor.author |
Jamieson, Stephen |
en |
dc.date.accessioned |
2019-10-08T09:21:34Z |
en |
dc.date.issued |
2019-07-01 |
en |
dc.identifier.citation |
CELLS 8(7):18 pages Article number ARTN 717 01 Jul 2019 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/48506 |
en |
dc.language |
English |
en |
dc.publisher |
MDPI |
en |
dc.relation.ispartofseries |
CELLS |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
https://creativecommons.org/licenses/by/4.0/ |
en |
dc.subject |
Science & Technology |
en |
dc.subject |
Life Sciences & Biomedicine |
en |
dc.subject |
Cell Biology |
en |
dc.subject |
tumour hypoxia |
en |
dc.subject |
head and neck squamous cell carcinoma (HNSCC) |
en |
dc.subject |
evofosfamide |
en |
dc.subject |
patient-derived xenograft (PDX) |
en |
dc.subject |
pimonidazole |
en |
dc.subject |
POR |
en |
dc.subject |
MKI67 |
en |
dc.subject |
SLFN11 |
en |
dc.subject |
ACTIVATED PRODRUG TH-302 |
en |
dc.subject |
ANTITUMOR-ACTIVITY |
en |
dc.subject |
CANCER-CELLS |
en |
dc.subject |
IN-VIVO |
en |
dc.subject |
THERAPY |
en |
dc.subject |
RADIOTHERAPY |
en |
dc.subject |
COMBINATION |
en |
dc.subject |
EXPRESSION |
en |
dc.subject |
IDENTIFICATION |
en |
dc.title |
Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.3390/cells8070717 |
en |
pubs.issue |
7 |
en |
pubs.volume |
8 |
en |
dc.rights.holder |
Copyright: The authors |
en |
pubs.author-url |
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478902000089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=6e41486220adb198d0efde5a3b153e7d |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Article |
en |
pubs.subtype |
Journal |
en |
pubs.elements-id |
779447 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Medical Sciences |
en |
pubs.org-id |
Pharmacology |
en |
pubs.org-id |
Science |
en |
pubs.org-id |
Science Research |
en |
pubs.org-id |
Maurice Wilkins Centre (2010-2014) |
en |
dc.identifier.eissn |
2073-4409 |
en |
pubs.number |
ARTN 717 |
en |